ClinicalTrials.govpublic full text
Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age
acellular pertussis, tetanus, diphtheria, hepatitis b, poliomyelitis, haemophilus influenzae type b, double-blind, finland, randomized, phase 2, gsk biologicals, dtpa-hbv-ipv/hib
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 904561
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.